“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation
A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation
Reviews
There are no reviews yet.
Be the first to review “Article: A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation” Cancel reply
Reviews
There are no reviews yet.